Literature DB >> 22706599

MicroRNA-31 modulates tumour sensitivity to radiation in oesophageal adenocarcinoma.

Niamh Lynam-Lennon1, John V Reynolds, Laure Marignol, Orla M Sheils, Graham P Pidgeon, Stephen G Maher.   

Abstract

Chemoradiation therapy (CRT) prior to surgery is increasingly the standard of care for locally advanced oesophageal cancer. Radiation therapy is important for local tumour control; however, tumour resistance to radiation is a substantial clinical problem. The mechanism(s) of radioresistance are still poorly understood, however, mounting evidence supports a role for microRNA (miRNA) in modulating key cellular pathways mediating response to radiation. Global miRNA profiling of an established isogenic model of radioresistance in oesophageal adenocarcinoma demonstrated a significant downregulation of miR-31 in radioresistant cells, both basally and in response to radiation. Ectopic re-expression of miR-31 significantly re-sensitised radioresistant cells to radiation. miR-31 was demonstrated to alter the expression of 13 genes involved in DNA repair, which is a critical cellular defence against radiation-induced DNA damage. In oesophageal tumours, miR-31 expression was significantly reduced in patients demonstrating poor histomorphologic response to neoadjuvant CRT, whilst expression of the miR-31-regulated DNA repair genes was significantly increased. Our data suggest a possible mechanism for resistance to CRT, potentially via enhanced DNA repair. This study demonstrates, for the first time, a role for miR-31 in modulating radioresistance and highlights the need for further study investigating the potential role of miR-31 as both a predictive marker of response and a novel therapeutic agent with which to enhance the efficacy of radiation therapy.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22706599     DOI: 10.1007/s00109-012-0924-x

Source DB:  PubMed          Journal:  J Mol Med (Berl)        ISSN: 0946-2716            Impact factor:   4.599


  34 in total

1.  Gene expression changes in mouse brain after exposure to low-dose ionizing radiation.

Authors:  E Yin; D O Nelson; M A Coleman; L E Peterson; A J Wyrobek
Journal:  Int J Radiat Biol       Date:  2003-10       Impact factor: 2.694

2.  Alterations in DNA repair efficiency are involved in the radioresistance of esophageal adenocarcinoma.

Authors:  Niamh Lynam-Lennon; John V Reynolds; Graham P Pidgeon; Joanne Lysaght; Laure Marignol; Stephen G Maher
Journal:  Radiat Res       Date:  2010-10-04       Impact factor: 2.841

3.  Molecular profiling uncovers a p53-associated role for microRNA-31 in inhibiting the proliferation of serous ovarian carcinomas and other cancers.

Authors:  Chad J Creighton; Michael D Fountain; Zhifeng Yu; Ankur K Nagaraja; Huifeng Zhu; Mahjabeen Khan; Emuejevoke Olokpa; Azam Zariff; Preethi H Gunaratne; Martin M Matzuk; Matthew L Anderson
Journal:  Cancer Res       Date:  2010-02-23       Impact factor: 12.701

Review 4.  Epidemiology of esophageal adenocarcinoma.

Authors:  Manuel Pera; Carlos Manterola; Oscar Vidal; Luis Grande
Journal:  J Surg Oncol       Date:  2005-12-01       Impact factor: 3.454

5.  Myc down-regulation sensitizes melanoma cells to radiotherapy by inhibiting MLH1 and MSH2 mismatch repair proteins.

Authors:  Barbara Bucci; Igea D'Agnano; Donatella Amendola; Arianna Citti; Giorgio H Raza; Roberto Miceli; Ugo De Paula; Rodolfo Marchese; Sonia Albini; Armando Felsani; Ercole Brunetti; Aldo Vecchione
Journal:  Clin Cancer Res       Date:  2005-04-01       Impact factor: 12.531

Review 6.  Genomic instability induced by ionizing radiation.

Authors:  W F Morgan; J P Day; M I Kaplan; E M McGhee; C L Limoli
Journal:  Radiat Res       Date:  1996-09       Impact factor: 2.841

7.  C --> T mutagenesis and gamma-radiation sensitivity due to deficiency in the Smug1 and Ung DNA glycosylases.

Authors:  Qian An; Peter Robins; Tomas Lindahl; Deborah E Barnes
Journal:  EMBO J       Date:  2005-05-19       Impact factor: 11.598

8.  Altered expression of miR-21, miR-31, miR-143 and miR-145 is related to clinicopathologic features of colorectal cancer.

Authors:  O Slaby; M Svoboda; P Fabian; T Smerdova; D Knoflickova; M Bednarikova; R Nenutil; R Vyzula
Journal:  Oncology       Date:  2008-01-15       Impact factor: 2.935

9.  Gene expression analysis of diagnostic biopsies predicts pathological response to neoadjuvant chemoradiotherapy of esophageal cancer.

Authors:  Stephen G Maher; Charles M Gillham; Shane P Duggan; Paul C Smyth; Nicola Miller; Cian Muldoon; Kenneth J O'Byrne; Orla M Sheils; Donal Hollywood; John V Reynolds
Journal:  Ann Surg       Date:  2009-11       Impact factor: 12.969

10.  Involvement of nucleotide excision and mismatch repair mechanisms in double strand break repair.

Authors:  Ye Zhang; Larry H Rohde; Honglu Wu
Journal:  Curr Genomics       Date:  2009-06       Impact factor: 2.236

View more
  50 in total

Review 1.  Predictive genetic markers in neoadjuvant chemoradiotherapy for locally advanced esophageal cancer: a long way to go. Review of the literature.

Authors:  M Gusella; E Pezzolo; Y Modena; C Barile; D Menon; G Crepaldi; F La Russa; A P Fraccon; F Pasini
Journal:  Pharmacogenomics J       Date:  2017-06-13       Impact factor: 3.550

2.  Role of miR-100 in the radioresistance of colorectal cancer cells.

Authors:  Xiao-Dong Yang; Xiao-Hui Xu; Shu-Yu Zhang; Yong Wu; Chun-Gen Xing; Gan Ru; Hong-Tao Xu; Jian-Ping Cao
Journal:  Am J Cancer Res       Date:  2015-01-15       Impact factor: 6.166

Review 3.  Current status of predictive biomarkers for neoadjuvant therapy in esophageal cancer.

Authors:  Norihisa Uemura; Tadashi Kondo
Journal:  World J Gastrointest Pathophysiol       Date:  2014-08-15

Review 4.  Function and regulation of microRNA-31 in development and disease.

Authors:  Nadezda A Stepicheva; Jia L Song
Journal:  Mol Reprod Dev       Date:  2016-08-02       Impact factor: 2.609

5.  MicroRNA-381 increases radiosensitivity in esophageal squamous cell carcinoma.

Authors:  Suna Zhou; Wenguang Ye; Juan Ren; Qiuju Shao; Yuhong Qi; Jun Liang; Mingxin Zhang
Journal:  Am J Cancer Res       Date:  2014-12-15       Impact factor: 6.166

Review 6.  Micro-RNAs in inflammatory diseases and as a link between inflammation and cancer.

Authors:  R Ranjha; J Paul
Journal:  Inflamm Res       Date:  2013-02-17       Impact factor: 4.575

Review 7.  Stabilization of miRNAs in esophageal cancer contributes to radioresistance and limits efficacy of therapy.

Authors:  Akshay Malhotra; Uttam Sharma; Shyamly Puhan; Naga Chandra Bandari; Anjali Kharb; P P Arifa; Lovlesh Thakur; Hridayesh Prakash; Karen M Vasquez; Aklank Jain
Journal:  Biochimie       Date:  2018-10-13       Impact factor: 4.079

8.  MicroRNA-31-5p modulates cell cycle by targeting human mutL homolog 1 in human cancer cells.

Authors:  Zhiwei Zhong; Zhuo Dong; Lihua Yang; Xiaoqiang Chen; Zhaohui Gong
Journal:  Tumour Biol       Date:  2013-03-29

9.  MicroRNA-31 sensitizes human breast cells to apoptosis by direct targeting of protein kinase C epsilon (PKCepsilon).

Authors:  Cindy Körner; Ioanna Keklikoglou; Christian Bender; Angelika Wörner; Ewald Münstermann; Stefan Wiemann
Journal:  J Biol Chem       Date:  2013-01-30       Impact factor: 5.157

10.  Low miR-187 expression promotes resistance to chemoradiation therapy in vitro and correlates with treatment failure in patients with esophageal adenocarcinoma.

Authors:  Niamh Lynam-Lennon; Becky A Bibby; Ann Marie Mongan; Laure Marignol; Christian N Paxton; Katherine Geiersbach; Mary P Bronner; Jacintha O'Sullivan; John Reynolds; Stephen G Maher
Journal:  Mol Med       Date:  2016-05-23       Impact factor: 6.354

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.